ALBEMARLE CORPORATION 
By BATON ROUGE, La., April 19, 2011 /PRNewswire/ --
First quarter 2011 highlights:
-- Achieved record quarterly earnings of $1.15 per share, up 67 percent
over first quarter 2010 results.
-- Record quarterly net sales performance of $697 million, up 20 percent
from prior year net sales of $580 million, including record net sales
performance for our Fine Chemistry segment.
-- Achieved all-time quarterly record income performance for all three of
our operating segments.
-- Record EBITDA generation of $171 million and EBITDA margin of 25 percent
for the quarter.
(Logo: http://photos.prnewswire.com/prnh/20050801/ALBEMARLELOGO )
Three Months Ended
March 31,
---------
In thousands, except per share amounts 2011 2010
-------------------------------------- ---- ----
Net Sales $696,530 $580,270
Segment income $171,600 $108,641
Net income attributable to Albemarle
Corporation $106,580 $63,308
Diluted earnings per share $1.15 $0.69
Special item per share $ - $0.05
--- -----
Diluted earnings per share excluding
special item $1.15 $0.74
===== =====
Albemarle Corporation (NYSE: ALB) reported first quarter 2011 earnings of $106.6 million, or $1.15 per share, compared to first quarter 2010 earnings of $63.3 million, or 69 cents per share. Excluding the $7.0 million ($4.6 million after tax, or 5 cents per share) charge for restructuring costs at our Bergheim, Germany site in the first quarter of 2010, earnings for the first quarter of 2010 were $67.9 million, or $0.74 per share. The Company reported net sales of $696.5 million in the first quarter of 2011 compared to net sales of $580.3 million in the first quarter of 2010.
Commenting on results, Mark C. Rohr, Chairman and CEO, stated, "I am extremely pleased with our performance this quarter as we achieved our highest quarterly earnings and EBITDA in the Company's history, as well as record income levels for all three of our operating segments. We continue to benefit from improving trends in the markets served by our businesses and our keen focus on cost control and cash generation. We expect the strength of our core technologies and key market insights to continue to drive solid earnings growth in 2011."
Quarterly Segment Results
Polymer Solutions delivered net sales of $258.2 million in the first quarter of 2011, a 19 percent increase over net sales in the first quarter of 2010, due primarily to favorable pricing. Segment income for Polymer Solutions was $69.5 million in the first quarter of 2011, a 66 percent increase from $41.8 million in the first quarter of 2010. This increase was due primarily to favorable pricing, partly offset by higher variable input costs and higher charges attributable to noncontrolling interests.
Catalysts generated net sales of $261.0 million in the first quarter of 2011, a 15 percent increase over net sales in the first quarter of 2010, due primarily to higher volumes and favorable pricing. Catalysts segment income was $72.6 million in the first quarter of 2011, a 32 percent increase from $55.1 million in the first quarter of 2010. This improvement was attributable primarily to higher volumes and favorable pricing, offset in part by higher variable input costs. Also, first quarter 2011 Catalysts segment income benefited from higher equity income versus first quarter 2010.
Fine Chemistry net sales in the first quarter of 2011 were $177.3 million, a 30 percent increase over net sales in the first quarter of 2010, due mainly to higher volumes as well as favorable pricing. Fine Chemistry segment income for the first quarter of 2011 was $29.5 million, up 151 percent compared to $11.8 million in the first quarter of 2010. This improvement in segment income was due primarily to higher volumes and favorable pricing, partly offset by higher variable input costs and higher charges attributable to noncontrolling interests.
Corporate and Other
Corporate and other expense was $23.6 million for the first quarter of 2011. The increase over the comparable period in 2010 was due mainly to higher personnel-related costs.
Cash Flow
In the three months ended March 31, 2011, cash on hand funded capital expenditures for plant, machinery and equipment of $31.9 million and dividends to shareholders of $12.9 million. Additionally, we made repayments of long-term debt of $100.6 million and pension and postretirement contributions of $51.9 million during the first quarter of 2011. Interest and financing expenses increased to $9.6 million for the first quarter of 2011 compared to $5.9 million for the first quarter of 2010, primarily due to higher average interest rates on our outstanding borrowings during the 2011 period. At March 31, 2011, the Company had $441.0 million in cash and cash equivalents.
Taxes
Our first quarter 2011 effective income tax rate was 24.2 percent versus 23.4 percent in the first quarter of 2010. Excluding the special item, our effective income tax rate for the first quarter of 2010 was 24.4 percent. Our effective tax rate continues to be influenced by the level and geographic mix of income and benefits from a favorable mix of income in lower tax jurisdictions.
Outlook
Positive market trends, coupled with continued success in new product development and rigorous cost controls, should provide the basis for strong top and bottom-line growth in 2011. Our balanced portfolio, geographic reach and commitment to operational excellence position Albemarle for long-term growth.
Earnings Call
The Company's performance for the first quarter ended March 31, 2011 will be discussed on a conference call at 9:00 AM Eastern Daylight time on April 20, 2011. The call can be accessed by dialing 866-700-6067 (International Dial In # 617-213-8834), and entering conference ID 61127439. The Company's earnings presentation and supporting material can be accessed through Albemarle's website under Investors at www.albemarle.com.
About Albemarle
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. Albemarle is committed to global sustainability and is continuing to advance its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry, with Corporate Responsibility Magazine naming Albemarle among its prestigious "100 Best Corporate Citizens" list for 2011. Albemarle employs approximately 4,000 people and serves customers in approximately 100 countries. Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings and other information regarding the Company, its businesses and markets served.
Forward-Looking Statements
Some of the information presented in this press release including, without limitation, statements with respect to product development, improvements in productivity, market trends, price and mix changes, expected growth and all other information relating to matters that are not historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There can be no assurance that actual results will not differ materially. Factors that could cause actual results to differ from expectations include, without limitation: deterioration in economic and business conditions; future financial and operating performance of our major customers and industries served by us; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in the demand for our products; limitations or prohibitions on the manufacture and sale of our products; availability of raw materials; changes in the cost of raw materials and energy, and our inability to pass through increases; performance of acquired companies; changes in our markets in general; fluctuations in foreign currencies; changes in laws and increased government regulation of our operations or our products; the occurrence of claims or litigation; the occurrence of natural disasters; the inability to maintain current levels of product or premises liability insurance or the denial of such coverage; political unrest affecting the global economy, including adverse effects from terrorism or hostilities; political unrest or instability affecting our manufacturing operations or joint ventures; changes in accounting standards; the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs; changes in the jurisdictional mix of our earnings; changes in interest rates, to the extent such rates (1) affect our ability to raise capital or increase our cost of funds, (2) have an impact on the overall performance of our pension fund investments and (3) increase our pension expense and funding obligations; volatility and substantial uncertainties in the debt and equity markets; technology or intellectual property infringement and other risks; and the other factors detailed from time to time in the reports we file with the SEC. Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found under "Risk Factors" in Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2010 and in our other public filings with the Securities and Exchange Commission. Readers are urged to review and consider carefully the disclosures we make in our filings with the Securities and Exchange Commission.
Albemarle Corporation and Subsidiaries
Consolidated Statements of Income
(In Thousands Except Per Share Amounts) (Unaudited)
Three Months Ended
March 31,
---------
2011 2010
---- ----
Net sales $696,530 $580,270
Cost of goods sold 463,514 415,799
------- -------
Gross profit 233,016 164,471
Selling, general and administrative
expenses 73,039 66,530
Research and development expenses 17,615 14,719
Restructuring and other charges (a) - 6,958
--- -----
Operating profit 142,362 76,264
Interest and financing expenses (9,592) (5,936)
Other income, net 338 1,010
--- -----
Income before income taxes and equity 133,108 71,338
in net income of unconsolidated investments
Income tax expense 32,172 16,700
------ ------
Income before equity in net income of 100,936 54,638
unconsolidated investments
Equity in net income of unconsolidated 12,831 10,276
investments (net of tax) ------ ------
Net income 113,767 64,914
Net income attributable to noncontrolling (7,187) (1,606)
interests ------ ------
Net income attributable to Albemarle $106,580 $63,308
Corporation ======== =======
Basic earnings per share $1.16 $0.69
Diluted earnings per share $1.15 $0.69
Weighted-average common shares outstanding
- Basic 91,633 91,386
Weighted-average common shares outstanding
- Diluted 92,517 92,193
See accompanying notes to the condensed consolidated financial
information.
Albemarle Corporation and Subsidiaries
Condensed Consolidated Balance Sheets
(In Thousands) (Unaudited)
December
March 31, 31,
2011 2010
---- ----
ASSETS
Cash and cash equivalents $441,013 $529,650
Other current assets 905,361 818,548
------- -------
Total current assets 1,346,374 1,348,198
--------- ---------
Property, plant and equipment 2,506,233 2,440,178
Less accumulated depreciation 1,466,228 1,433,865
and amortization --------- ---------
Net property, plant and equipment 1,040,005 1,006,313
Other assets and intangibles 753,502 713,570
------- -------
Total assets $3,139,881 $3,068,081
========== ==========
LIABILITIES AND EQUITY
Current portion of long-term debt $9,097 $8,983
Other current liabilities 372,514 355,194
------- -------
Total current liabilities 381,611 364,177
------- -------
Long-term debt 758,597 851,927
Other noncurrent liabilities 213,420 266,661
Deferred income taxes 123,585 109,570
Albemarle Corporation shareholders' equity 1,596,109 1,416,074
Noncontrolling interests 66,559 59,672
------ ------
Total liabilities & equity $3,139,881 $3,068,081
========== ==========
See accompanying notes to the condensed consolidated financial
information.
Albemarle Corporation and Subsidiaries
Selected Consolidated Cash Flow Data
(In Thousands) (Unaudited)
Three Months Ended
March 31,
---------
2011 2010
Cash and cash equivalents at beginning of
year $529,650 $308,791
Cash and cash equivalents at end of period $441,013 $267,317
Sources of cash and cash equivalents:
Net income 113,767 64,914
Proceeds from borrowings 6,694 6,654
Proceeds from exercise of stock options 205 978
Uses of cash and cash equivalents:
Capital expenditures (31,894) (16,141)
Repurchases of common stock - (8,634)
Repayments of long-term debt (100,622) (14,445)
Dividends paid to shareholders (12,856) (11,401)
Pension and postretirement contributions (51,949) (22,209)
Cash impact from deconsolidation of Stannica
JV, net - (13,074)
Investments in equity and other corporate
investments (10,666) -
Non-cash items:
Depreciation and amortization 23,004 24,701
Restructuring and other charges (a) - 6,958
Equity in net income of unconsolidated
investments (12,831) (10,276)
See accompanying notes to the condensed consolidated financial
information.
Albemarle Corporation and Subsidiaries
Consolidated Summary of Segment Results
(In Thousands) (Unaudited)
Three Months Ended
March 31,
---------
2011 2010
---- ----
Net sales:
Polymer Solutions $258,223 $216,653
Catalysts 260,957 227,653
Fine Chemistry 177,350 135,964
------- -------
Total net sales $696,530 $580,270
======== ========
Segment operating profit:
Polymer Solutions $69,831 $40,363
Catalysts 62,131 46,995
Fine Chemistry 33,959 12,568
------ ------
Subtotal $165,921 $99,926
======== =======
Equity in net income of unconsolidated
investments:
Polymer Solutions $2,489 $2,194
Catalysts 10,461 8,109
Fine Chemistry - -
Corporate & other (119) (27)
---- ---
Total equity in net income of unconsolidated
investments $12,831 $10,276
======= =======
Net income attributable to noncontrolling
interests:
Polymer Solutions $(2,846) $(790)
Catalysts - -
Fine Chemistry (4,425) (798)
Corporate & other 84 (18)
--- ---
Total net income attributable to
noncontrolling interests $(7,187) $(1,606)
======= =======
Segment income:
Polymer Solutions $69,474 $41,767
Catalysts 72,592 55,104
Fine Chemistry 29,534 11,770
Total segment income 171,600 108,641
Corporate & other (23,594) (16,749)
Restructuring and other charges (a) - (6,958)
Interest and financing expenses (9,592) (5,936)
Other income, net 338 1,010
Income tax expense (32,172) (16,700)
------- -------
Net income attributable to Albemarle
Corporation $106,580 $63,308
======== =======
See accompanying notes to the condensed consolidated financial
information.
Notes to the Condensed Consolidated Financial Information
(a) The quarter ended March 31, 2010 included charges amounting to
$7.0 million ($4.6 million after
income taxes, or 5 cents per share) that related principally to
planned reductions in force at our Bergheim,
Germany site.
Additional Information
It should be noted that earnings or per share amounts excluding special items, EBITDA, EBITDA excluding special items, EBITDA margin, EBITDA margin excluding special items, segment operating profit and segment income are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These measures are presented here to provide additional useful measurements to review our operations, provide transparency to investors and enable period-to-period comparability of financial performance.
A description of other non-GAAP financial measures that we use to evaluate our operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, can be found in the Investors section of our website at www.albemarle.com, under "Non-GAAP Reconciliations" under "Financials." Also, see attached for a supplemental reconciliation of our segment operating profit and segment income amounts to GAAP Operating profit and GAAP Net income attributable to Albemarle Corporation, respectively, as well as for a supplemental reconciliation of our GAAP Net income attributable to Albemarle Corporation to EBITDA and EBITDA excluding special items.
ALBEMARLE CORPORATION AND SUBSIDIARIES
Non-GAAP Reconciliation
(In Thousands)
(Unaudited)
Our segment information includes measures we refer to as "segment operating profit," "segment income," "EBITDA" and "EBITDA excluding special items," which are financial measures that are not required by, or presented in accordance with, GAAP. The Company has reported segment operating profit, segment income, EBITDA and EBITDA excluding special items because management believes that these financial measures provide transparency to investors and enable period-to-period comparability of financial performance. Segment operating profit, segment income, EBITDA and EBITDA excluding special items should not be considered as alternatives to operating profit or net income attributable to Albemarle Corporation, as determined in accordance with GAAP.
See below for a reconciliation of segment operating profit and segment income, the non-GAAP financial measures, to operating profit and net income attributable to Albemarle Corporation, respectively, the most directly comparable financial measures calculated and reported in accordance with GAAP.
Three Months Ended
March 31,
---------
2011 2010
---- ----
Total segment operating profit $165,921 $99,926
Corporate & other * (23,559) (16,704)
Restructuring and other charges - (6,958)
GAAP Operating profit $142,362 $76,264
======== =======
Total segment income $171,600 $108,641
Corporate & other (23,594) (16,749)
Restructuring and other charges - (6,958)
Interest and financing expenses (9,592) (5,936)
Other income, net 338 1,010
Income tax expense (32,172) (16,700)
------- -------
GAAP Net income attributable to Albemarle
Corporation $106,580 $63,308
======== =======
* Excludes corporate equity income and noncontrolling interest
adjustments of ($35) and ($45) for the three-month periods ended
March 31, 2011 and 2010, respectively.
See below for a reconciliation of EBITDA and EBITDA excluding special items, the non-GAAP financial measures, from net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. EBITDA is defined as Net income attributable to Albemarle Corporation before interest and financing expenses, income taxes, depreciation and amortization. EBITDA excluding special items is defined as EBITDA before the special item as listed below.
Three Months Ended
March 31,
---------
2011 2010
---- ----
Net income attributable to Albemarle
Corporation $106,580 $63,308
======== =======
Add:
Interest and financing expenses 9,592 5,936
Income tax expense 32,172 16,700
Depreciation and amortization 23,004 24,701
------ ------
EBITDA 171,348 110,645
Restructuring and other charges - 6,958
EBITDA excluding special item $171,348 $117,603
======== ========
Net Sales $696,530 $580,270
======== ========
EBITDA Margin 24.6% 19.1%
==== ====
EBITDA Margin excluding special item 24.6% 20.3%
==== ====
SOURCE Albemarle Corporation
